Anne L. Peters
University of Southern California
Internal medicineEndocrinologyHealth careRandomized controlled trialIntensive care medicinePhysical therapyPediatricsType 2 diabetesInsulinMEDLINEGlycemicOverweightHypoglycemiaType 1 diabetesPopulationObesityFamily medicineWeight lossDiabetes mellitusMedicineGerontology
271Publications
67H-index
24.7kCitations
Publications 262
Newest
Source
#1Thomas W. MartensH-Index: 2
#2Roy W. BeckH-Index: 116
Last. Richard M. Bergenstal (HealthPartners)H-Index: 18
view all 24 authors...
Importance Continuous glucose monitoring (CGM) has been shown to be beneficial for adults with type 2 diabetes using intensive insulin therapy, but its use in type 2 diabetes treated with basal insulin without prandial insulin has not been well studied. Objective To determine the effectiveness of CGM in adults with type 2 diabetes treated with basal insulin without prandial insulin in primary care practices. Design, Setting, and Participants This randomized clinical trial was conducted at 15 cen...
1 CitationsSource
Source
#1Tadej BattelinoH-Index: 52
#2Timothy S. BaileyH-Index: 30
Last. Linda A. DiMeglioH-Index: 61
view all 0 authors...
The efficacy of dasiglucagon 0.6 mg has been investigated in multiple trials in individuals with T1DM. The primary endpoint was time to plasma glucose (PG) recovery from insulin-induced hypoglycemia, defined as first PG increase ≥20 mg/dL after treatment initiation without the need for IV glucose. Different PG sampling schemes were used in phase 2 (5-min intervals) versus phase 3 trials (more frequent sampling). Estimating the true but unmeasured time to recovery for each individual enables for ...
Source
Last. Anne L. Peters (SC: University of Southern California)H-Index: 67
view all 5 authors...
Source
#1Bruce W. BodeH-Index: 67
#2Anne L. Peters (SC: University of Southern California)H-Index: 67
Last. Trang T. LyH-Index: 24
view all 8 authors...
Source
Background:Knowledge regarding the burden and predictors of hypoglycemia among older adults with type 1 diabetes (T1D) is limited.Methods:We analyzed baseline data from the Wireless Innovations for...
3 CitationsSource
Source
Continuous glucose monitoring (CGM) and the metrics surrounding its use have become increasingly integrated into the world of diabetes management. However, these tools require that people have access to the devices and providers who can help interpret them. I remember when I first heard about time in range (TIR) as a concept from Dr. Richard M. Bergenstal. Initially, I was a bit dubious. I was used to looking at my beloved “spaghetti graphs” and viewing the individual colorful linear representat...
Source
#1Emma G Wilmot (Burton Snowboards)H-Index: 10
#2Kelly L. CloseH-Index: 17
Last. Jochen SeufertH-Index: 32
view all 13 authors...
AIMS This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions. MATERIALS AND METHODS SAGE was a multinational, cross-sectional, observational study in adults with T1DM. Data were collected at a single visit, analysed according to predefined age groups (26-44, 45-64, and ≥65 years), and reported across different regions. PRO questionnaire...
Source